Healthcare Trust, Inc. — Form 10-Q Summary
Filing identity: The supplied filing identifies the registrant as Healthcare Trust, Inc., not National Healthcare Properties, Inc. The report covers the quarter and six months ended June 30, 2022 and was filed August 12, 2022.
Business context and reporting period
Healthcare Trust is an externally managed REIT focused on medical office and other healthcare-related buildings and seniors housing operating properties. As of June 30, 2022, it owned 201 properties in 33 states encompassing approximately 9.1 million rentable square feet: 149 MOB properties, 50 SHOP properties and two land parcels.
The company operates through two reportable segments: medical office buildings (MOBs) and seniors housing operating properties (SHOPs). The company continued paying common-stock distributions in shares rather than cash. Estimated per-share NAV was $15.00 as of December 31, 2021.
Financial performance and key metrics
| Metric | Three months ended June 30 | Six months ended June 30 |
|---|---|---|
| Revenue from tenants | $83.8 million, versus $81.2 million | $167.5 million, versus $164.6 million |
| NOI | $31.2 million, versus $29.6 million | $61.8 million, versus $63.7 million |
| NOI margin | 37.3%, versus 36.5% | 36.9%, versus 38.7% |
| Net loss | $17.6 million, versus $14.1 million | $41.0 million, versus $25.5 million |
| Net loss attributable to common stockholders | $21.1 million, or $0.20 per share | $47.9 million, or $0.46 per share |
| FFO attributable to stockholders | $4.9 million, versus $6.6 million | $9.0 million, versus $15.0 million |
| MFFO attributable to stockholders | $4.6 million, versus $5.7 million | $8.4 million, versus $13.4 million |
Six-month operating cash flow was $13.7 million, down from $17.6 million in the prior-year period. Investing cash flow used $15.1 million, including $17.8 million for three property acquisitions and $9.1 million of capital expenditures, partially offset by $11.8 million of disposition proceeds. Financing cash flow used $14.5 million, primarily for mortgage principal payments and preferred-stock dividends.
At June 30, 2022, cash and cash equivalents were $42.7 million and restricted cash was $26.8 million. Gross debt was approximately $1.1 billion, consisting of $585.7 million of mortgage notes and $504.0 million of credit facilities before deferred financing costs. Total debt leverage was approximately 40.8% of gross asset value, and the weighted-average interest rate was 3.76%.
Material changes versus the prior comparable period
- Revenue increased 3.3% in the quarter and 1.8% year to date, but profitability deteriorated because expenses increased faster than revenue.
- Six-month impairment charges rose to $16.8 million from $7.0 million. The 2022 charges included $10.6 million on seven Illinois skilled-nursing properties and $6.2 million on two SHOP properties.
- SHOP NOI declined $1.2 million in the quarter and $6.9 million year to date. Same-store SHOP operating expenses increased substantially because of contract labor, agency costs, overtime, bonuses and inflation.
- SHOP occupancy improved to 76.3% at June 30, 2022 from 73.2% at June 30, 2021, but remained well below the 85.1% level at December 31, 2019. MOB occupancy was 91.4%, with a 4.9-year weighted-average remaining lease term.
- Contract labor and agency costs for SHOP care providers increased by $2.7 million in the quarter and $4.7 million year to date versus the prior-year periods.
- Preferred-stock distributions increased to $6.9 million year to date from $2.6 million, reflecting the Series B preferred stock issued in October 2021.
- Net derivative assets increased to $23.7 million from a net derivative liability of $13.7 million at December 31, 2021, primarily because of higher interest rates.
Guidance, outlook, risks and unusual items
Management did not provide formal earnings guidance. It stated that liquidity is expected to be sufficient for at least the next 12 months, subject to the continuing effects of COVID-19, inflation, labor shortages, supply-chain disruptions, interest rates and tenant performance.
On August 11, 2022, lenders entered into a Fourth Amendment to the credit facility because the company would otherwise have violated the prior 1.50-to-1.00 fixed-charge coverage covenant for the four quarters ended June 30, 2022. The amended covenant was reduced to 1.20-to-1.00 through June 30, 2023, with scheduled increases thereafter. The amendment also added a debt-service coverage covenant, reduced the borrowing-base advance rate from 55% to 52.5% until the Commencement Quarter, and provided for the transition from LIBOR to SOFR.
The company had $212.5 million of unused revolver availability, including $89.0 million available for general corporate purposes and acquisitions. It did not meet the conditions to designate the quarter ending September 30, 2022 as the Commencement Quarter. Until that quarter occurs, common-stock cash distributions and share repurchases remain restricted; common distributions continued in stock.
Subsequent to quarter-end, the company received $4.3 million of CARES Act grants. It also began marketing certain SHOP properties for sale, although no properties were classified as held for sale at June 30, 2022. The company disclosed no material pending legal or regulatory proceedings.
Most important facts for investors to verify
- Confirm the registrant name and ticker information because the requested company name differs from the filing’s identified registrant, Healthcare Trust, Inc.
- Review the Fourth Amendment and subsequent covenant compliance, including the revised fixed-charge and debt-service coverage requirements.
- Assess refinancing and maturity risk, particularly the approximately $156.9 million of scheduled 2024 principal payments and approximately $396.7 million due in 2026.
- Monitor SHOP occupancy, labor costs, inflation and the ability to reduce reliance on contract staffing.
- Evaluate the assumptions supporting the $16.8 million of 2022 impairments and the potential sale of the affected properties.
- Consider the sustainability of preferred-stock distributions and stock-only common distributions in light of $13.7 million of operating cash flow and a $41.0 million six-month GAAP net loss.
- Review exposure to variable-rate debt, the LIBOR-to-SOFR transition and the effectiveness of interest-rate caps and swaps.